Keyword: Themis Bioscience


Themis Biosciences heading to Zika vaccine human trials

Even as some of the world’s largest drugmakers ante up in the Zika vaccine hunt, some smaller biotechs are looking to play their part in the search for a viable vaccine. Now, Austrian company Themis Bioscience says it’s planning to run clinical trials within 12 months through a partnership with Institut Pasteur.